BDR-166

N/A

Report date: 2023/10/27 17:56:51
NME

Base Information

Drug NameBDR-166
Drug Alias NameBDR-166
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionFAS-associated factor 1 inhibitors
TargetsFAS-associated factor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMDimune IncKainos Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesMDimune Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A